Related Experiment Video
Updated: Sep 1, 2025
06:20
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
7.3K
[Clinical trials in Radiation Oncology: Methodologic approach]
1Unité de biométrie, ICM, institut régional du cancer montpellier, université de Montpellier, avenue des Apothicaires, 34298 Montpellier cedex 05, France.
Summary
Clinical trials in radiation oncology face challenges due to diverse treatments. New methods like Bayesian analysis and real-world data are proposed to improve treatment effectiveness evaluation.
Area of Science:
- Radiation oncology
- Clinical trial methodology
- Medical assessment
Background:
- Curative radiation oncology treatments require rigorous follow-up for tolerance evaluation.
- Diverse treatment modalities and technologies complicate medical assessment and effectiveness studies.
- Randomized controlled trials (RCTs) are the standard but face feasibility limitations.
Purpose of the Study:
- To present the current limitations of clinical trial methodologies in radiation oncology.
- To propose novel methodological approaches for evaluating treatment effectiveness.
- To address the challenges in assessing acute and late tolerance.
Main Methods:
- Discussing limitations of traditional randomized controlled trials.
- Proposing alternative and complementary methodological approaches.
- Highlighting the need for updated statistical analyses.
Main Results:
- Co-primary endpoints or pragmatic composite endpoints are recommended.
- Bayesian methods offer a viable statistical approach.
- Re-use of real-world data (RWD) and external control arms are beneficial.
Conclusions:
- Innovative methodological approaches are crucial for radiation oncology clinical development.
- Integrating real-world data registers enhances the evaluation of treatment effectiveness.
- Advanced statistical methods can overcome current study limitations.
More Related Videos
08:34Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.5K
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022
2.9K
Related Concept Videos
01:16Clinical Trials
7.0K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
7.0K
01:11Clinical Trials: Overview
3.3K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.3K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
164
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
164
01:12Hazard Ratio
224
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
224
01:21Cancer Survival Analysis
433
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
433
01:11Blinding
2.5K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.5K